High delayed mortality after the first episode of Clostridium difficile infection
Copyright © 2019. Published by Elsevier Ltd..
Clostridium difficile infection (CDI) is characterized by a high delayed and unrelated mortality. Predicting delayed mortality in CDI patients could allow the implementation of interventions that could reduce these events. A prospective multicentric study was carried out to investigate prognostic factors associated with mortality. It was based on a cohort (July 2015 to February 2016) of 295 patients presenting with CDI. Logistic regression was used and the model was calibrated using the Hosmer-Lemeshow test. The mortality rate at 75 days in our series was 18%. Age (>65 years), comorbidity (defined by heart failure, diabetes mellitus with any organ lesion, renal failure, active neoplasia or immunosuppression) and fecal incontinence at clinical presentation were associated with delayed (75-day) mortality. When present, each of the aforementioned variables added one point to the score. Mortalities with 0, 1, 2 and 3 points were 0%, 9.4%, 18.5% and 38.2%, respectively. The area under the ROC curve was 0.743, and the Hosmer-Lemeshow goodness-of-fit test p value was 0.875. Therefore, the prediction of high delayed mortality in CDI patients by our scoring system could promote measures for increasing survival in suitable cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Anaerobe - 57(2019) vom: 28. Juni, Seite 93-98 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cózar, Alberto [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aged |
---|
Anmerkungen: |
Date Completed 05.11.2019 Date Revised 05.11.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.anaerobe.2019.04.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295806680 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295806680 | ||
003 | DE-627 | ||
005 | 20231225084450.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.anaerobe.2019.04.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n0986.xml |
035 | |a (DE-627)NLM295806680 | ||
035 | |a (NLM)30959165 | ||
035 | |a (PII)S1075-9964(19)30071-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cózar, Alberto |e verfasserin |4 aut | |
245 | 1 | 0 | |a High delayed mortality after the first episode of Clostridium difficile infection |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.11.2019 | ||
500 | |a Date Revised 05.11.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019. Published by Elsevier Ltd. | ||
520 | |a Clostridium difficile infection (CDI) is characterized by a high delayed and unrelated mortality. Predicting delayed mortality in CDI patients could allow the implementation of interventions that could reduce these events. A prospective multicentric study was carried out to investigate prognostic factors associated with mortality. It was based on a cohort (July 2015 to February 2016) of 295 patients presenting with CDI. Logistic regression was used and the model was calibrated using the Hosmer-Lemeshow test. The mortality rate at 75 days in our series was 18%. Age (>65 years), comorbidity (defined by heart failure, diabetes mellitus with any organ lesion, renal failure, active neoplasia or immunosuppression) and fecal incontinence at clinical presentation were associated with delayed (75-day) mortality. When present, each of the aforementioned variables added one point to the score. Mortalities with 0, 1, 2 and 3 points were 0%, 9.4%, 18.5% and 38.2%, respectively. The area under the ROC curve was 0.743, and the Hosmer-Lemeshow goodness-of-fit test p value was 0.875. Therefore, the prediction of high delayed mortality in CDI patients by our scoring system could promote measures for increasing survival in suitable cases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Aged | |
650 | 4 | |a Clostridium difficile | |
650 | 4 | |a Comorbidity | |
650 | 4 | |a Fecal incontinence | |
650 | 4 | |a Immunosuppression | |
650 | 4 | |a Mortality | |
700 | 1 | |a Ramos-Martínez, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Merino, Esperanza |e verfasserin |4 aut | |
700 | 1 | |a Martínez-García, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Shaw, Evelyn |e verfasserin |4 aut | |
700 | 1 | |a Marrodán, Teresa |e verfasserin |4 aut | |
700 | 1 | |a Calbo, Esther |e verfasserin |4 aut | |
700 | 1 | |a Bereciartúa, Elena |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Muñoz, Luis A |e verfasserin |4 aut | |
700 | 1 | |a Salavert, Miguel |e verfasserin |4 aut | |
700 | 1 | |a Pérez-Rodríguez, M Teresa |e verfasserin |4 aut | |
700 | 1 | |a García, Dácil |e verfasserin |4 aut | |
700 | 1 | |a Bravo-Ferrer, J María |e verfasserin |4 aut | |
700 | 1 | |a Gálvez-Acebal, Juan |e verfasserin |4 aut | |
700 | 1 | |a Henríquez, César |e verfasserin |4 aut | |
700 | 1 | |a Cuquet, Jordi |e verfasserin |4 aut | |
700 | 1 | |a Gil-Campesino, Helena |e verfasserin |4 aut | |
700 | 1 | |a Torres, Luis |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Porto, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Royuela, Ana |e verfasserin |4 aut | |
700 | 1 | |a Cobo, Javier |e verfasserin |4 aut | |
700 | 0 | |a Study group |e verfasserin |4 aut | |
700 | 1 | |a Romero, José |e investigator |4 oth | |
700 | 1 | |a Muriel, Alfonso |e investigator |4 oth | |
700 | 1 | |a Giner, Livia |e investigator |4 oth | |
700 | 1 | |a Federico, Ferrere |e investigator |4 oth | |
700 | 1 | |a Rocío, Martínez-Ruiz S |e investigator |4 oth | |
700 | 1 | |a Martos, Purificación |e investigator |4 oth | |
700 | 1 | |a Sardiña, Cristina |e investigator |4 oth | |
700 | 1 | |a Elena, Aguirre |e investigator |4 oth | |
700 | 1 | |a Badía, Cristina |e investigator |4 oth | |
700 | 1 | |a Perales, Alfonso |e investigator |4 oth | |
700 | 1 | |a De Santos-Castro, Pedro A |e investigator |4 oth | |
700 | 1 | |a Miguel, AngelBratos-Pérez |e investigator |4 oth | |
700 | 1 | |a Cuellar, Sandra |e investigator |4 oth | |
700 | 1 | |a Eva, Gonzalez |e investigator |4 oth | |
700 | 1 | |a Llinares, Pedro |e investigator |4 oth | |
700 | 1 | |a Laura, Castelo |e investigator |4 oth | |
700 | 1 | |a Morales, Isabel |e investigator |4 oth | |
700 | 1 | |a Delgado-Iribarren, Alberto |e investigator |4 oth | |
700 | 1 | |a Mairal, Pilar |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Anaerobe |d 1995 |g 57(2019) vom: 28. Juni, Seite 93-98 |w (DE-627)NLM094469687 |x 1095-8274 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2019 |g day:28 |g month:06 |g pages:93-98 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anaerobe.2019.04.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 57 |j 2019 |b 28 |c 06 |h 93-98 |